SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-059378
Filing Date
2011-03-08
Accepted
2011-03-08 16:58:31
Documents
5
Period of Report
2010-12-25

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 908003
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex23.htm EX-23 2151
3 RULE 13A-14(A)/15D-14(A) CERTIFICATION dex311.htm EX-31.1 6873
4 SECTION 1350 CERTIFICATION dex32.htm EX-32 3586
5 GRAPHIC g157153g18c28.jpg GRAPHIC 38729
  Complete submission text file 0001193125-11-059378.txt   975411
Mailing Address 12276 WILKINS AVENUE ROCKVILLE MD 20852
Business Address 12276 WILKINS AVENUE ROCKVILLE MD 20852 301-770-3099
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1226
Type: 10-K | Act: 34 | File No.: 000-04829 | Film No.: 11672614
SIC: 2836 Biological Products, (No Diagnostic Substances)